ELV · Elevance Health Inc
United States · RS rating 94 · As of 2026-10-14
| Price | 428.09 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 83 / 89 / 77 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 57 / 54 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | -53.6% |
| Sales growth Q/Q | -1.9% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $75.2B |